| Stage | BRK-B | % of rev | KNSL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $455M | 100.00% | BRK-B ×223.85 |
| Gross profit | $55.9B | 54.87% | $223M | 48.97% | BRK-B +5.9pp |
| Operating income | $17.1B | 16.77% | $127M | 27.89% | KNSL +11.1pp |
| Pre-tax income | $31.8B | 31.25% | $124M | 27.18% | BRK-B +4.1pp |
| Net income | $25.8B | 25.31% | $98M | 21.58% | BRK-B +3.7pp |
| Stage | BRK-B | KNSL | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $455M100.00% | BRK-B ×223.85 |
| Gross profit | 54.87%$55.9B | 48.97%$223M | BRK-B +5.9pp |
| Operating income | 16.77%$17.1B | 27.89%$127M | KNSL +11.1pp |
| Pre-tax income | 31.25%$31.8B | 27.18%$124M | BRK-B +4.1pp |
| Net income |
| 25.31%$25.8B |
| 21.58%$98M |
| BRK-B +3.7pp |
None
No disclosed counterparties: BRK-B.